Search Ontology:
ChEBI
EVP4593
- Term ID
- CHEBI:232358
- Synonyms
-
- 4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine
- 6-amino-4-(4-phenoxyphenylethylamino)quinazoline
- 6-amino-4-[2-(4-phenoxyphenyl)ethylamino]quinazoline
- AG-F-89549
- CAY 10470
- CAY-10470
- CAY10470
- EVP 4593
- EVP-4593
- N(4)-(4-phenoxyphenethyl)quinazoline-4,6-diamine
- N(4)-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine
- N(4)-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine
- QNZ
- Definition
- A member of the class of quinazolines that is quinazoline substituted by [2-(4-phenoxyphenyl)ethyl]amino and amino groups at positions 4 and 6, respectively. It is an inhibitor of NF-κB signal transduction pathway and exhibits protective effects in oncology, cardiovascular disease and parasite invasion.
- References
-
- cas:545380-34-5
- hmdb:HMDB0246942
- lincs.smallmolecule:LSM-45149
- pubmed:21700213
- pubmed:28000898
- pubmed:28302490
- pubmed:28693192
- pubmed:30108783
- pubmed:30194168
- pubmed:30638515
- pubmed:30704052
- pubmed:31055008
- pubmed:32432727
- pubmed:34564023
- pubmed:34722891
- pubmed:35871734
- pubmed:36349549
- pubmed:36552336
- pubmed:36555369
- pubmed:36805135
- pubmed:37175413
- pubmed:37179969
- pubmed:37256224
- pubmed:38095503
- pubmed:39120322
- pubmed:39268468
- reaxys:9350957
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from EVP4593
Phenotype where environments contain EVP4593
Phenotype modified by environments containing EVP4593
Phenotype affecting EVP4593
Human Disease Model